Nicholas, Richard

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis

Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 858

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis

Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 747

Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.

Choi, S. R., Howell, O. W., Carassiti, D., Magliozzi, R., Gveric, D., Muraro, P. A., Nicholas, R., Roncaroli, F., & Reynolds, R. (2012) · Brain

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 386

Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis

Papadopoulos, D., Dukes, S., Patel, R., Nicholas, R., Vora, A., & Reynolds, R. (2009) · Brain Pathology

Multiple Sclerosis Research StudiesNeurological Disease Mechanisms and Treatments

Cited by 192

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

Politis, M., Giannetti, P., Su, P., Turkheimer, F., Keihaninejad, S., Wu, K., Waldman, A., Malik, O., Matthews, P. M., Reynolds, R., et al. (2012) · Neurology

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 176

In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with18F-PBR111 PET

Colasanti, A., Guo, Q., Muhlert, N., Giannetti, P., Onega, M., Newbould, R. D., Ciccarelli, O., Rison, S., Thomas, C., Nicholas, R., et al. (2014) · Journal of Nuclear Medicine

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 100

Lipoprotein markers associated with disability from multiple sclerosis

Gafson, A. R., Thorne, T., McKechnie, C. I. J., Jimenez, B., Nicholas, R., & Matthews, P. M. (2018) · Scientific Reports

Multiple Sclerosis Research StudiesLipoproteins and Cardiovascular Health

Cited by 40

The four self-efficacy trajectories among people with multiple sclerosis: clinical associations and implications

Young, C. A., Mills, R., Langdon, D., Sharrack, B., Majeed, T., Kalra, S., Footitt, D., Rog, D., Harrower, T., Nicholas, R., et al. (2022) · Journal of the Neurological Sciences

Multiple Sclerosis Research StudiesCancer survivorship and care

Cited by 10

Cellular Senescence Correlates with Demyelination, Brain Atrophy and Motor Impairment in a Model of Multiple Sclerosis (P2.405)

Karamita, M., Nicholas, R., Kokoti, L., Rizou, S., Mitsikostas, D. D., Gorgoulis, V., Probert, L., & Papadopoulos, D. (2018) · Neurology

Multiple Sclerosis Research StudiesTelomeres, Telomerase, and Senescence

Cited by 8